Bioorganic and Medicinal Chemistry Letters p. 5709 - 5712 (2004)
Update date:2022-08-05
Topics:
Romagnoli, Romeo
Baraldi, Pier Giovanni
Pavani, Maria Giovanna
Tabrizi, Mojgan Aghazadeh
Moorman, Allan R.
Di Virgilio, Francesco
Cattabriga, Elena
Pancaldi, Cecilia
Gessi, Stefania
Borea, Pier Andrea
The design, synthesis, and preliminary biological evaluation of the first potent radioligand antagonist for the P2X7 receptor, named [ 3H]-1-[(S)-N,O-bis-(isoquinolinesulfonyl)-N-methyl-tyrosyl] -4-(o-tolyl)-piperazine (compound 13),
View MoreContact:86 513 85512619
Address:Rm.1306, Building A, Wenfeng Mansion,168 Gongnong Road, Nantong Jiangsu China
Jinan Hongfangde Pharmatech Co.,Ltd
Contact:86-531-88870908
Address:F Bldg. West Unit North Area of Univ. Tech. Garden Xinyu Rd. Jinan New & High Tech Industry Development Zone Shandong, China
Shanghai Zhihua ChemTech Co., Ltd.
Contact:+86-13774313779
Address:Room 817 Suite B 3333 Shenjiang Road
Jiangsu Jiuri Chemical Co.,Ltd.
Contact:+86-519-82118868
Address:Tianwang Town, Jurong City, Jiangsu Province, China
zhejiang huangyan wanfeng pharm chem co.ltd
Contact:+86-576- 84160728
Address:No. 5 Dazha Road, Economic,Development Zone(JiangKou), Zhejiang, China
Doi:10.1071/CH9812231
(1981)Doi:10.1016/0008-6215(82)84037-8
(1982)Doi:10.1039/P19810002997
(1981)Doi:10.1016/S0040-4039(01)82047-5
(1981)Doi:10.1021/acs.orglett.0c01924
(2020)Doi:10.1039/b412584c
(2004)